FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100636 [Registered on: 09/01/2026] Trial Registered Prospectively
Last Modified On: 08/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Assessment of age related muscle loss and its impact on daily activities in elderly individuals  
Scientific Title of Study   Prevalence Of Sarcopenia And Its Association With Muscle Strength And Mass In Elderly Patients 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sri krisna ananth KS 
Designation  Postgraduate 
Affiliation  Vinayaka missions kirupananda variyar medical college hospitals 
Address  Vinayaka missions kirupananda variyar medical college hospitals sankari main road NH47 Seeragapadi Ariyanoor salem 636308

Salem
TAMIL NADU
636308
India 
Phone  9500664497  
Fax    
Email  kssrikrisnaananth98@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Arulmurugan 
Designation  Professor Head of department 
Affiliation  Vinayaka missions kirupananda variyar medical college hospitals 
Address  Vinayaka missions kirupananda variyar medical college hospitals sankari main road NH47 Seeragapadi Ariyanoor salem 636308

Salem
TAMIL NADU
636308
India 
Phone  8248646877  
Fax    
Email  dr.arulc@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sri krisna ananth KS 
Designation  Postgraduate 
Affiliation  Vinayaka missions kirupananda variyar medical college hospitals 
Address  Vinayaka missions kirupananda variyar medical college hospitals sankari main road NH47 Seeragapadi Ariyanoor salem 636308

Salem
TAMIL NADU
636308
India 
Phone  9500664497  
Fax    
Email  kssrikrisnaananth98@gmail.com  
 
Source of Monetary or Material Support  
Vinayaka missions kirupananda variyar medical college hospitals Salem 636308 Tamil Nadu INDIA 
 
Primary Sponsor  
Name  Sri krisna ananth KS 
Address  Vinayaka missions kirupananda variyar medical college hospitals sankari main road NH47 Seeragapadi Ariyanoor salem 636308 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sri Krisna ananth KS  Vinayaka missions kirupananda variyar medical college and hospitals salem  Opd no 16 Department of general Medicine Vinayaka missions kirupananda variyar medical college and hospitals salem
Salem
TAMIL NADU 
9500664497

kssrikrisnaananth98@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Vinayaka Missions Kirupananda Variyar Medical College and Hospital , Instituitional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M628||Other specified disorders of muscle,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  60.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  willing to participate in physical performance test
age greater than 60 years
type 2 Diabetes patient more than 5 years 
 
ExclusionCriteria 
Details  bedridden patients
terminal illness or malignancy
patient on corticosteroids , chemotherapy, pacemaker,metal implants
amputees or those with musculoskeletal deformities 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The study is expected to determine the prevalence of sarcopenia and its correlation with muscle strength and mass. It will aid in early identification and timely interventions to prevent frailty and improve quality of life in the elderly.  This study will assess how common age-related muscle loss is among elderly people and how it is related to muscle strength and muscle size. Measurements will be taken at the start of the study, after 4 weeks, and after 8 weeks. The results may help in early detection of muscle loss and support timely measures to reduce frailty and improve quality of life in older adults. 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Sarcopenia is a geriatric syndrome characterized by progressive loss of skeletal muscle strength and mass contributing to frailty falls disability and reduced quality of life in elderly individuals. Early identification of sarcopenia is essential for timely intervention yet its prevalence and clinical correlates remain insufficiently explored in the Indian elderly population. This cross sectional observational study aims to determine the prevalence of sarcopenia among elderly patients above 60 years attending the outpatient and inpatient departments of General Medicine at VMKVMCH Salem and to evaluate its association with muscle strength and muscle mass. A total of approximately 200 participants will be recruited based on predefined inclusion and exclusion criteria. Muscle strength will be assessed using handgrip dynamometry and muscle mass will be measured using bioelectrical impedance analysis BIA. Sarcopenia will be diagnosed using EWGSOP2 criteria where low muscle strength indicates probable sarcopenia and low muscle mass confirms the diagnosis. Descriptive statistics will estimate prevalence while chi square and correlation analyses will assess associations between sarcopenia muscle strength and muscle mass. The findings are expected to provide epidemiological data on sarcopenia in the regional elderly population and support early screening strategies to prevent functional decline. The study may contribute to improved geriatric assessment protocols and guide future interventional research 
Close